Table 1.
Compound | Cytotoxicity | Leishmanicidal Activity | |
---|---|---|---|
LC50 (μg/mL) | EC50 (μg/mL) | SI* | |
6 | 27.6 ± 5.9 | 37.9 ± 1.4 | 0.7 |
7 | 54.1 ± 3.1 | 22.2 ± 3.2 | 2.4 |
8 | 3.5 ± 0.4 | 0.8 ± 0.2 | 4.4 |
9 | 33.9 ± 1.4 | 2.8 ± 0.8 | 12.1 |
10 | 1.4 ± 0.1 | 4.5 ± 0.3 | 0.3 |
11 | 0.4 ± 0.03 | 1.6 ± 0.2 | 0.3 |
12 | 1.0 ± 0.04 | 8.6 ± 0.3 | 0.1 |
13 | 2.5 ± 0.3 | 7.5 ± 2.1 | 0.3 |
14 | 2.2 ± 0.3 | 1.9 ± 0.1 | 1.2 |
15 | 1.0 ± 0.01 | 1.4 ± 0.3 | 0.7 |
16 | 51.2 ± 6.0 | 47.2 ±10.3 | 1.1 |
3.7** | 0.20** | 18.5** | |
4.0** | 0.22** | 18.1** | |
45.1** | 3.42** | 13.2** | |
Glucantime | 416.4 | 6.7 | 59.6 |
*SI=LC50/EC50; ** biological results reported in the literature [10].